Jaeger Veronika K, Wirz Elina G, Allanore Yannick, Rossbach Philipp, Riemekasten Gabriela, Hachulla Eric, Distler Oliver, Airò Paolo, Carreira Patricia E, Balbir Gurman Alexandra, Tikly Mohammed, Vettori Serena, Damjanov Nemanja, Müller-Ladner Ulf, Distler Jörg H W, Li Mangtao, Walker Ulrich A
Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
Department of Dermatology, University Hospital Basel, Basel, Switzerland.
PLoS One. 2016 Oct 5;11(10):e0163894. doi: 10.1371/journal.pone.0163894. eCollection 2016.
Systemic sclerosis (SSc) is a rare and clinically heterogeneous autoimmune disorder characterised by fibrosis and microvascular obliteration of the skin and internal organs. Organ involvement mostly manifests after a variable period of the onset of Raynaud's phenomenon (RP). We aimed to map the incidence and predictors of pulmonary, cardiac, gastrointestinal (GI) and renal involvement in the early course of SSc.
In the EUSTAR cohort, patients with early SSc were identified as those who had a visit within the first year after RP onset. Incident SSc organ manifestations and their risk factors were assessed using Kaplan-Meier methods and Cox regression analysis.
Of the 695 SSc patients who had a baseline visit within 1 year after RP onset, the incident non-RP manifestations (in order of frequency) were: skin sclerosis (75%) GI symptoms (71%), impaired diffusing capacity for monoxide<80% predicted (65%), DU (34%), cardiac involvement (32%), FVC<80% predicted (31%), increased PAPsys>40mmHg (14%), and renal crisis (3%). In the heart, incidence rates were highest for diastolic dysfunction, followed by conduction blocks and pericardial effusion. While the main baseline risk factor for a short timespan to develop FVC impairment was diffuse skin involvement, for PAPsys>40mmHg it was higher patient age. The main risk factors for incident cardiac manifestations were anti-topoisomerase autoantibody positivity and older age. Male sex, anti-RNA-polymerase-III positivity, and older age were risk factors associated with incident renal crisis.
In SSc patients presenting early after RP onset, approximately half of all incident organ manifestations occur within 2 years and have a simultaneous rather than a sequential onset. These findings have implications for the design of new diagnostic and therapeutic strategies aimed to 'widen' the still very narrow 'window of opportunity'. They may also enable physicians to counsel and manage patients presenting early in the course of SSc more accurately.
系统性硬化症(SSc)是一种罕见的、临床异质性自身免疫性疾病,其特征为皮肤和内脏器官的纤维化及微血管闭塞。器官受累大多在雷诺现象(RP)发作后的一段可变时期后出现。我们旨在明确SSc早期病程中肺部、心脏、胃肠道(GI)和肾脏受累的发生率及预测因素。
在EUSTAR队列中,早期SSc患者被确定为RP发作后1年内就诊的患者。使用Kaplan-Meier方法和Cox回归分析评估SSc器官表现的发生率及其危险因素。
在RP发作后1年内进行基线就诊的695例SSc患者中,非RP的新发表现(按频率排序)为:皮肤硬化(75%)、GI症状(71%)、一氧化碳弥散能力受损<预测值的80%(65%)、十二指肠溃疡(DU,34%)、心脏受累(32%)、用力肺活量(FVC)<预测值的80%(31%)、收缩期肺动脉压(PAPsys)升高>40mmHg(14%)以及肾危象(3%)。在心脏方面,舒张功能障碍的发生率最高,其次是传导阻滞和心包积液。FVC受损发展的主要基线危险因素是弥漫性皮肤受累,而对于PAPsys>40mmHg,主要危险因素是患者年龄较大。新发心脏表现的主要危险因素是抗拓扑异构酶自身抗体阳性和年龄较大。男性、抗RNA聚合酶III阳性和年龄较大是与新发肾危象相关的危险因素。
在RP发作后早期就诊的SSc患者中,所有新发器官表现约一半在2年内出现,且多为同时出现而非相继出现。这些发现对旨在“拓宽”目前仍非常狭窄的“机会窗口”的新诊断和治疗策略的设计具有启示意义。它们还可能使医生能够更准确地为SSc病程早期的患者提供咨询和管理。